| answer text |
<p><strong> </strong></p><p>The information is not available in the format requested.
Such information as is available is shown in the table below and is from reference
costs, which are the average unit cost to National Health Service trusts and foundation
trusts of providing defined services in a given financial year. Reference costs are
published annually, with most recently available data being for 2014-15.</p><p> </p><p>Reference
costs for acute care are collected by healthcare resource group (HRG), which are standard
groupings of clinically similar treatments that consume similar levels of healthcare
resource. HRGs are organised by chapters and sub-chapters, representing different
body systems, and HRG sub-chapters GC and PG describe hepatobiliary and pancreatic
system disorders for adults and children respectively. The average costs in the following
table will therefore include the costs to NHS hospitals of treating hepatitis C and
cirrhosis, as well as the costs of other related disorders.</p><p> </p><p>These costs
do not include high cost drugs, or treatment in outpatient or other settings outside
of hospital. They reflect the costs of a single episode of care under one consultant
for a patient admitted to hospital. Patients admitted to hospital may have multiple
episodes of care and each one of these episodes will be recorded separately.</p><p>
</p><p> </p><p>Table: Average cost to NHS hospitals of treating hepatobiliary and
pancreatic system disorders, 2014-15 (excluding high cost drugs, or treatment in outpatient
or other settings outside of hospital)</p><table><tbody><tr><td><p> </p></td><td><p>Average
cost per unit of activity (£)</p></td></tr><tr><td><p>Non-Malignant, Hepatobiliary
or Pancreatic Disorders</p></td><td><p>1,751</p></td></tr><tr><td><p>Paediatric, Hepatobiliary
or Pancreatic Disorders</p></td><td><p>2,344</p></td></tr></tbody></table><p><em>Source:
</em>Reference costs, Department of Health</p><p> </p><p><em>Notes:</em></p><ol><li>The
following HRGs are included in the table:</li></ol><p>GC17A Non-Malignant, Hepatobiliary
or Pancreatic Disorders, with Multiple Interventions, with CC Score 9+</p><p>GC17B
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Multiple Interventions,
with CC Score 4-8</p><p>GC17C Non-Malignant, Hepatobiliary or Pancreatic Disorders,
with Multiple Interventions, with CC Score 0-3</p><p>GC17D Non-Malignant, Hepatobiliary
or Pancreatic Disorders, with Single Intervention, with CC Score 9+</p><p>GC17E Non-Malignant,
Hepatobiliary or Pancreatic Disorders, with Single Intervention, with CC Score 4-8</p><p>GC17F
Non-Malignant, Hepatobiliary or Pancreatic Disorders, with Single Intervention, with
CC Score 0-3</p><p>GC17G Non-Malignant, Hepatobiliary or Pancreatic Disorders, without
Interventions, with CC Score 8+</p><p>GC17H Non-Malignant, Hepatobiliary or Pancreatic
Disorders, without Interventions, with CC Score 5-7</p><p>GC17J Non-Malignant, Hepatobiliary
or Pancreatic Disorders, without Interventions, with CC Score 2-4</p><p>GC17K Non-Malignant,
Hepatobiliary or Pancreatic Disorders, without Interventions, with CC Score 0-1</p><p>PG71A
Paediatric, Hepatobiliary or Pancreatic Disorders, with CC Score 2+</p><p>PG71B Paediatric,
Hepatobiliary or Pancreatic Disorders, with CC Score 1</p><p>PG71C Paediatric, Hepatobiliary
or Pancreatic Disorders, with CC Score 0</p><ol start="2"><li>These HRGs are common
groupings of the ICD-10 codes used to count the number of finished admission episodes
with a primary or secondary diagnosis of hepatitis C or cirrhosis. They also include
other ICD-10 codes.</li><li>For each HRG or other currency in the reference cost collection,
NHS hospital trusts submit a unit cost and amount of activity undertaken.</li></ol><p><strong>
</strong></p>
|
|
